Storage and recording of Restricted Schedule 4 (S4R) medicines

Applicable to: All health professionals handling medicines in WA Health and authorised under the Poisons Regulations 1965 to obtain or possess Schedule 4 medicines.

Description: This Operational Directive outlines the requirements for the storage and recording of Restricted Schedule 4 (S4R) medicines.

Legal requirements: These are additional controls over and above the minimum required for other Schedule 4 medicines as outlined in the Western Australian Poisons Regulations 1965.

Storage and recording of Restricted Schedule 4 (S4R) medicines

There is a range of Schedule 4 medicines that are liable to abuse, such as benzodiazepines and tramadol. For this group of medicines, the traditional storage and record keeping requirements for a Schedule 4 medicine are not considered adequate to provide the level of accountability required in the public health system. 

For this reason, additional controls are indicated over and above the minimum required for other Schedule 4 medicines.

In addition to legislative requirements, all authorised health practitioners in WA Health are to comply with the Storage and recording of Restricted Schedule 4 (S4R) medicines policy. This policy represents the minimum requirements for the secure and accountable management of Restricted Schedule 4 medicines (S4R).

The medicines listed within the Storage and recording of Restricted Schedule 4 (S4R) medicines policy are those to be classified as restricted.

Where the risk of loss, theft or misuse is higher or a specific need identified, hospitals and health services may choose to implement additional local controls or policy requirements for S4R medicines. A hospital or area health service may decide to add additional medicines to the S4R list for local purposes.

Where these requirements are not considered appropriate, on clinical or other grounds, a written assessment is to be performed and alternative controls applied consistent with the level of risk. This must be approved by the relevant area health service and a copy provided to the Pharmaceutical Services Branch of the Department of Health.


Professor Bryant Stokes
A/DIRECTOR GENERAL
DEPARTMENT OF HEALTH WA

Date of effect: 01 June 2014 to 01 June 2024

Policy Framework

Related documents

Supporting information